Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

CCI has imposed Rs 64 crore fine on GlaxoSmithKline, Sanofi

The Competition Commission of India on account of a collusive bidding in supply of a meningitis vaccine to the government for Haj pilgrims, has imposed a penalty of Rs 64 crore on GlaxoSmithKline Pharmaceuticals and Sanofi.

The government every year invites tenders for purchase of meningitis vaccine which is required to be administered upon Haj pilgrims.

The Competition Commission, apart from imposing the penalties has directed both the companies to “cease and desist” from the anti competitive practices.

A fine of Rs 60.45 crore has been slapped on GlaxoSmithKline and Rs 3.04 crore on Sanofi, the Competition Commission of India (CCI) said.

Learn share trading

Get Daily Prediction & Stocks Tips On Your Mobile